BlueCross BlueShield of Tennessee will remove...

...Oxycontin from its formulary in 2019, in favor of Xtampza and Morphabond, which are designed to deter opioid abuse. Though both drugs are more expensive than Oxycontin, the insurer said it will absorb the additional cost to members. Oxycontin is still one of the most advantaged narcotic painkillers, and currently holds preferred-tier status for 35% of covered lives, and 47% including plans that require step therapy.